{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:17:58Z","timestamp":1758050278648,"version":"3.44.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bulcan.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T08:59:43Z","timestamp":1557133183000},"page":"574-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-prise de greffe allog\u00e9nique de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: d\u00e9finition et facteurs de risque identifi\u00e9s"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-6286","authenticated-orcid":false,"given":"Vincent","family":"Alcazer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Labussi\u00e8re-Wallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2019.03.009_bib0295","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/leu.2015.75","article-title":"Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"29","author":"Olsson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0300","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bmt.2016.356","article-title":"Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature","volume":"52","author":"Mallhi","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0305","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2016.00362","article-title":"Immunological basis of bone marrow failure after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Masouridi-Levrat","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0310","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0315","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24111","article-title":"Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure: outcomes of HCT After Graft Failure","volume":"90","author":"Lund","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0320","first-page":"935","article-title":"Boost of CD34+ \u2013 selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation","volume":"91","author":"Larocca","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0325","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","article-title":"Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a Single Institution Analysis","volume":"14","author":"Rond\u00f3n","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0330","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/10428194.2014.930849","article-title":"Outcome of graft failure after allogeneic stem cell transplant: study of 89\u00a0patients","volume":"56","author":"Ferr\u00e0","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0335","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00007890-199002000-00042","article-title":"Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrow","volume":"49","author":"Nakamura","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","article-title":"Graft failure after allogeneic hematopoietic cell transplantation","volume":"14","author":"Mattsson","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0345","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","article-title":"Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program","volume":"96","author":"Davies","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0350","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","article-title":"Second unrelated donor hematopoietic cell transplantation for primary graft failure","volume":"16","author":"Schriber","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0355","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1111\/j.1399-0012.2010.01324.x","article-title":"Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure","volume":"25","author":"Remberger","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0580","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.13650","article-title":"Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation","volume":"171","author":"Cesaro","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.2014.852537","article-title":"Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Locatelli","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0375","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2012.02.014","article-title":"Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation","volume":"18","author":"Fuji","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0380","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.23845","article-title":"Outcomes and management strategies for graft failure after umbilical cord blood transplantation: graft failure after UCBT","volume":"89","author":"Singh","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0385","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bmt.2011.84","article-title":"Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning","volume":"47","author":"Yoshihara","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0390","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3324\/haematol.12798","article-title":"Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation","volume":"93","author":"Platzbecker","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0395","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bmt.2012.249","article-title":"Effects of spleen status on early outcomes after hematopoietic cell transplantation","volume":"48","author":"Akpek","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0400","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2002-12-3742","article-title":"Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation","volume":"102","author":"Plett","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bulcan.2019.03.009_bib0405","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/bmt.2015.351","article-title":"Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI","volume":"51","author":"Cluzeau","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0410","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"K\u00f6rbling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0415","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0585","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ajh.24342","article-title":"Impact of HLA-Mismatch in unrelated donor hematopoietic stem cell transplantation: a meta-analysis","volume":"91","author":"Kekre","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0425","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1\u00a0in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0430","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0435","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","article-title":"Major ABO Blood Group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation","volume":"13","author":"Remberger","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0440","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2005-08-3374","article-title":"Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1\u00a0disparity in host-versus-graft direction","volume":"107","author":"Fleischhauer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0445","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2014.10.015","article-title":"Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation","volume":"21","author":"Kanda","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0450","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1182\/blood-2013-01-480343","article-title":"The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors","volume":"121","author":"Hurley","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0455","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1016\/j.bulcan.2016.09.005","article-title":"Polymorphisme des g\u00e8nes HLA et KIR et l\u2019impact sur le devenir de la greffe et le choix du donneur non apparent\u00e9 de cellules souche h\u00e9matopo\u00ef\u00e9tiques\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"103","author":"Dubois","year":"2016","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0460","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1537-2995.2010.02589.x","article-title":"Identification of specificities of antibodies against human leukocyte antigens in blood donors","volume":"50","author":"Endres","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0465","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2016.00307","article-title":"Donor-specific anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Morin-Zorman","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0470","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1182\/blood-2011-05-355263","article-title":"Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation","volume":"118","author":"Cutler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0475","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1182\/blood-2011-06-362111","article-title":"Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation","volume":"118","author":"Ciurea","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0480","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.bbmt.2011.04.013","article-title":"Anti-HLA antibodies in double umbilical cord blood transplantation","volume":"17","author":"Brunstein","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0485","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.exphem.2012.06.003","article-title":"Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens","volume":"40","author":"Detrait","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0490","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/asheducation-2017.1.645","article-title":"HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities","volume":"1","author":"Gladstone","year":"2017","journal-title":"Hematol-Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0495","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of Donor-specific Anti-HLA Antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0500","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.trim.2011.06.001","article-title":"Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Nordlander","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0505","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/j.bulcan.2016.09.007","article-title":"Greffe de cellules-souches h\u00e9matopo\u00ef\u00e9tiques haplo-identiques\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"103","author":"Nguyen","year":"2016","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0510","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood.V50.2.185.185","article-title":"ABO blood group system and bone marrow transplantation","volume":"50","author":"Gale","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0515","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0609.1999.tb01115.x","article-title":"Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation","volume":"62","author":"Tazzari","year":"1999","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0525","first-page":"148","article-title":"Skin","volume":"2","author":"Eichwald","year":"1955","journal-title":"Transplant Bull"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0530","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.thj.6200117","article-title":"Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants","volume":"2","author":"Gratwohl","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0535","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.tp.0000226156.99206.d1","article-title":"Influence of donor\/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia","volume":"82","author":"Stern","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0540","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood.V74.6.2227.2227","article-title":"Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I.\u00a0Analysis of risk factors and results of secondary transplants","volume":"74","author":"Kernan","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0545","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3324\/haematol.2016.147645","article-title":"Donor and recipient sex in allogeneic stem cell transplantation: what really matters","volume":"101","author":"Kim","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0550","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0555","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/01.TP.0000129809.09718.7E","article-title":"A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation","volume":"78","author":"Le Blanc","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0560","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/bloodadvances.2016001560","article-title":"ATG in allogeneic stem cell transplantation: standard of care in 2017?","volume":"1","author":"Bacigalupo","year":"2017","journal-title":"Point Blood Adv"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0565","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/bloodadvances.2016001552","article-title":"ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint","volume":"1","author":"Kekre","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0570","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","article-title":"Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT","volume":"11","author":"Ruggeri","year":"2018","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0575","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbmt.2014.08.014","article-title":"Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease","volume":"21","author":"Al-Homsi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2019.03.009_bib0290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.exphem.2014.07.264","article-title":"Human herpesvirus 6\u00a0reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults","volume":"42","author":"Le Bourgeois","year":"2014","journal-title":"Exp Hematol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119301602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119301602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:30:29Z","timestamp":1757791829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455119301602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0007455119301602"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.03.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-prise de greffe allog\u00e9nique de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: d\u00e9finition et facteurs de risque identifi\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}